These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 14769357)
1. Microglial response is poorly correlated with neurodegeneration following chronic, low-dose MPTP administration in monkeys. Hurley SD; O'Banion MK; Song DD; Arana FS; Olschowka JA; Haber SN Exp Neurol; 2003 Dec; 184(2):659-68. PubMed ID: 14769357 [TBL] [Abstract][Full Text] [Related]
2. Acute and chronic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administrations elicit similar microglial activation in the substantia nigra of monkeys. Vázquez-Claverie M; Garrido-Gil P; San Sebastián W; Izal-Azcárate A; Belzunegui S; Marcilla I; López B; Luquin MR J Neuropathol Exp Neurol; 2009 Sep; 68(9):977-84. PubMed ID: 19680145 [TBL] [Abstract][Full Text] [Related]
3. Long-lasting reactive changes observed in microglia in the striatal and substantia nigral of mice after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Yasuda Y; Shinagawa R; Yamada M; Mori T; Tateishi N; Fujita S Brain Res; 2007 Mar; 1138():196-202. PubMed ID: 17275793 [TBL] [Abstract][Full Text] [Related]
4. Interleukin-18 null mice show diminished microglial activation and reduced dopaminergic neuron loss following acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment. Sugama S; Wirz SA; Barr AM; Conti B; Bartfai T; Shibasaki T Neuroscience; 2004; 128(2):451-8. PubMed ID: 15350655 [TBL] [Abstract][Full Text] [Related]
5. Evidence of active microglia in substantia nigra pars compacta of parkinsonian monkeys 1 year after MPTP exposure. Barcia C; Sánchez Bahillo A; Fernández-Villalba E; Bautista V; Poza Y Poza M; Fernández-Barreiro A; Hirsch EC; Herrero MT Glia; 2004 May; 46(4):402-9. PubMed ID: 15095370 [TBL] [Abstract][Full Text] [Related]
6. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease. Novikova L; Garris BL; Garris DR; Lau YS Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572 [TBL] [Abstract][Full Text] [Related]
7. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure fails to produce delayed degeneration of substantia nigra neurons in monkeys. Garrido-Gil P; Belzunegui S; San Sebastián W; Izal-Azcárate A; López B; Marcilla I; Luquin MR J Neurosci Res; 2009 Feb; 87(2):586-97. PubMed ID: 18798285 [TBL] [Abstract][Full Text] [Related]
8. Microglial activation is inhibited by corticosterone in dopaminergic neurodegeneration. Sugama S; Takenouchi T; Kitani H; Fujita M; Hashimoto M J Neuroimmunol; 2009 Mar; 208(1-2):104-14. PubMed ID: 19201037 [TBL] [Abstract][Full Text] [Related]
9. Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor-alpha. Sriram K; Miller DB; O'Callaghan JP J Neurochem; 2006 Feb; 96(3):706-18. PubMed ID: 16405514 [TBL] [Abstract][Full Text] [Related]
10. Upregulation of microglial C1q expression has no effects on nigrostriatal dopaminergic injury in the MPTP mouse model of Parkinson disease. Depboylu C; Schorlemmer K; Klietz M; Oertel WH; Weihe E; Höglinger GU; Schäfer MK J Neuroimmunol; 2011 Jul; 236(1-2):39-46. PubMed ID: 21640391 [TBL] [Abstract][Full Text] [Related]
11. Activated microglia affect the nigro-striatal dopamine neurons differently in neonatal and aged mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Sawada H; Hishida R; Hirata Y; Ono K; Suzuki H; Muramatsu S; Nakano I; Nagatsu T; Sawada M J Neurosci Res; 2007 Jun; 85(8):1752-61. PubMed ID: 17469135 [TBL] [Abstract][Full Text] [Related]
12. Dietary restriction affects striatal glutamate in the MPTP-induced mouse model of nigrostriatal degeneration. Holmer HK; Keyghobadi M; Moore C; Menashe RA; Meshul CK Synapse; 2005 Aug; 57(2):100-12. PubMed ID: 15906381 [TBL] [Abstract][Full Text] [Related]
13. Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a radical scavenger, prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the substantia nigra but not the striatum. Kawasaki T; Ishihara K; Ago Y; Baba A; Matsuda T J Pharmacol Exp Ther; 2007 Jul; 322(1):274-81. PubMed ID: 17429058 [TBL] [Abstract][Full Text] [Related]
14. Differences between subacute and chronic MPTP mice models: investigation of dopaminergic neuronal degeneration and alpha-synuclein inclusions. Gibrat C; Saint-Pierre M; Bousquet M; Lévesque D; Rouillard C; Cicchetti F J Neurochem; 2009 Jun; 109(5):1469-82. PubMed ID: 19457163 [TBL] [Abstract][Full Text] [Related]
15. Tyrosine hydroxylase and dopamine transporter expression following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of the mouse nigrostriatal pathway. Jakowec MW; Nixon K; Hogg E; McNeill T; Petzinger GM J Neurosci Res; 2004 May; 76(4):539-50. PubMed ID: 15114626 [TBL] [Abstract][Full Text] [Related]
16. Presence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration. McGeer PL; Schwab C; Parent A; Doudet D Ann Neurol; 2003 Nov; 54(5):599-604. PubMed ID: 14595649 [TBL] [Abstract][Full Text] [Related]
17. Estrogen attenuates the MPTP-induced loss of dopamine neurons from the mouse SNc despite a lack of estrogen receptors (ERalpha and ERbeta). Shughrue PJ Exp Neurol; 2004 Dec; 190(2):468-77. PubMed ID: 15530885 [TBL] [Abstract][Full Text] [Related]
18. Neuroprotection in Parkinson models varies with toxin administration protocol. Anderson DW; Bradbury KA; Schneider JS Eur J Neurosci; 2006 Dec; 24(11):3174-82. PubMed ID: 17156378 [TBL] [Abstract][Full Text] [Related]
19. Quantification of MPTP-induced dopaminergic neurodegeneration in the mouse substantia nigra by laser capture microdissection. Stephenson D; Ramirez A; Long J; Barrezueta N; Hajos-Korcsok E; Matherne C; Gallagher D; Ryan A; Ochoa R; Menniti F; Yan J J Neurosci Methods; 2007 Jan; 159(2):291-9. PubMed ID: 16949674 [TBL] [Abstract][Full Text] [Related]
20. Neurotoxic-related changes in tyrosine hydroxylase, microglia, myelin, and the blood-brain barrier in the caudate-putamen from acute methamphetamine exposure. Bowyer JF; Robinson B; Ali S; Schmued LC Synapse; 2008 Mar; 62(3):193-204. PubMed ID: 18081184 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]